{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:59:32Z","timestamp":1792886372775,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ymgme.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,5]],"date-time":"2016-06-05T19:32:55Z","timestamp":1465155175000},"page":"232-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pathogenesis and treatment of spine disease in the mucopolysaccharidoses"],"prefix":"10.1016","volume":"118","author":[{"given":"Sun H.","family":"Peck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret L.","family":"Casal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ficicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.06.002_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2016.06.002_bb0010","first-page":"102","article-title":"Mucopolysaccharidosis type I","volume":"12","author":"Wraith","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.20828","article-title":"Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly syndrome)","volume":"30","author":"Tomatsu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0020","series-title":"Essentials of Glycobiology","article-title":"Proteoglycans and sulfated glycosaminoglycans","author":"Esko","year":"2009"},{"issue":"Suppl. 96","key":"10.1016\/j.ymgme.2016.06.002_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1651-2227.2007.00211.x","article-title":"Animal models for mucopolysaccharidosis disorders and their clinical relevance","author":"Haskins","year":"2007","journal-title":"Acta. Paediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0030","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1097\/01.BRS.0000112074.48566.FA","article-title":"Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma","volume":"29","author":"Dickerman","year":"2004","journal-title":"Spine"},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2016.06.002_bb0035","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2012.03.014","article-title":"Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII","volume":"107","author":"Smith","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0045","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1073\/pnas.69.8.2048","article-title":"The defect in the Hurler and Scheie syndromes: deficiency of -l-iduronidase","volume":"69","author":"Bach","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0050","first-page":"969","article-title":"Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis","volume":"82","author":"Glaser","year":"1973","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0055","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1073\/pnas.87.21.8531","article-title":"Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng1295-465","article-title":"Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome","volume":"11","author":"Scott","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BPO.0b013e31821f5ee9","article-title":"Musculoskeletal manifestations of Sanfilippo syndrome (mucopolysaccharidosis type III)","volume":"31","author":"White","year":"2011","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis","volume":"82","author":"Sly","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0075","first-page":"132","article-title":"Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency","volume":"7","author":"Vogler","year":"1994","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1302\/0301-620X78B6.1279","article-title":"Spinal problems in mucopolysaccharidosis I (Hurler syndrome)","volume":"78","author":"Tandon","year":"1996","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0085","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/08035250510031584","article-title":"Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I","volume":"94","author":"Vijay","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0006-291X(91)91244-7","article-title":"Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase","volume":"181","author":"Tomatsu","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.1320010205","article-title":"Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity: mucopolysacchariodosis IVB","volume":"1","author":"Arbisser","year":"1977","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2013.06.008","article-title":"Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels","volume":"110","author":"Dung","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International morquio a registry: clinical manifestation and natural course of morquio A disease","volume":"30","author":"Montano","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_330","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/geno.1995.9962","article-title":"Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation","volume":"29","author":"Kunieda","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI113317","article-title":"Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-l-iduronidase activities","volume":"81","author":"Schuchman","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0545","article-title":"Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis","volume":"369","author":"Matsuo","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10024-005-0025-8","article-title":"Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse","volume":"8","author":"Vogler","year":"2005","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0140","first-page":"49","article-title":"Prenatal diagnosis and genetic counseling of mucopolysaccharidosis type II (Hunter syndrome)","volume":"18","author":"Chen","year":"2007","journal-title":"Genet. Couns."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0145","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.0803715105","article-title":"Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1083\/jcb.200212083","article-title":"QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling","volume":"162","author":"Ai","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1083\/jcb.200307053","article-title":"Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly","volume":"163","author":"Allen","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/abbi.1995.1032","article-title":"Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes","volume":"316","author":"Chintala","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0165","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1242\/dev.030742","article-title":"Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate","volume":"136","author":"Cortes","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.matbio.2005.07.008","article-title":"Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation","volume":"25","author":"Fisher","year":"2006","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.matbio.2010.05.001","article-title":"Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling","volume":"29","author":"Gualeni","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1681","article-title":"Heparan sulphate proteoglycans: the sweet side of development","volume":"6","author":"Hacker","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.matbio.2013.11.003","article-title":"Heparan sulfate as a regulator of endochondral ossification and osteochondroma development","volume":"34","author":"Jochmann","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.devcel.2004.05.009","article-title":"Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification","volume":"6","author":"Koziel","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1042\/BST0340458","article-title":"Heparin\/heparan sulphate binding in the TGF-beta cytokine superfamily","volume":"34","author":"Rider","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0200","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1634\/stemcells.2007-0065","article-title":"Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways","volume":"25","author":"Manton","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0205","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcp.21557","article-title":"Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation","volume":"217","author":"Miyazaki","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092381","article-title":"Biphasic role of chondroitin sulfate in cardiac differentiation of embryonic stem cells through inhibition of Wnt\/beta-catenin signaling","volume":"9","author":"Prinz","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0215","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/bm5006855","article-title":"Sulfated glycosaminoglycans exploit the conformational plasticity of bone morphogenetic protein-2 (BMP-2) and alter the interaction profile with its receptor","volume":"15","author":"Hintze","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.140.2.409","article-title":"Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes","volume":"140","author":"Enomoto-Iwamoto","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0225","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1242\/dev.029926","article-title":"BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation","volume":"136","author":"Retting","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050044","article-title":"Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function","volume":"5","author":"Tsang","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0235","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1242\/dev.043281","article-title":"Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription","volume":"136","author":"Wang","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0240","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/dvdy.24131","article-title":"Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia","volume":"243","author":"Patterson","year":"2014","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.physiol.67.040403.103635","article-title":"Molecular and evolutionary basis of the cellular stress response","volume":"67","author":"Kultz","year":"2005","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.068833","article-title":"In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences","volume":"123","author":"Tsang","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0255","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0260","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/306378a0","article-title":"An interleukin 1 like factor stimulates bone resorption in vitro","volume":"306","author":"Gowen","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0265","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jbmr.5650030607","article-title":"Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice","volume":"3","author":"Konig","year":"1988","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0270","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar2275","article-title":"Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile","volume":"9","author":"Le Maitre","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0275","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.27444","article-title":"Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues","volume":"62","author":"Shamji","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0280","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 91","key":"10.1016\/j.ymgme.2016.06.002_bb0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/glycob\/11.1.99","article-title":"A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant","volume":"11","author":"Bhattacharyya","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0295","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0300","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","article-title":"Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0305","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9975(08)80258-7","article-title":"Pathological characteristics of mucopolysaccharidosis VI in the rat","volume":"109","author":"Yoshida","year":"1993","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0315","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI116268","article-title":"Arylsulfatase B-deficient mucopolysaccharidosis in rats","volume":"91","author":"Yoshida","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/geno.1994.1147","article-title":"The locus responsible for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) is located on rat chromosome 2","volume":"20","author":"Yoshida","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0325","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1073\/pnas.93.16.8214","article-title":"Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI","volume":"93","author":"Evers","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0330","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI114010","article-title":"Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency","volume":"83","author":"Birkenmeier","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0335","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.90.14.6567","article-title":"A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII","volume":"90","author":"Sands","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0340","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2014.09.012","article-title":"Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I","volume":"114","author":"Heppner","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0345","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","author":"Rowan","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0350","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities","volume":"175","author":"Wilson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0355","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/hmg\/ddn088","article-title":"A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. [Erratum appears in Hum Mol Genet. 2008 Sep 15;17(18):2919 note: Csoka, Antonei B [added]]","volume":"17","author":"Martin","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0360","first-page":"622","article-title":"Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain","volume":"53","author":"Gografe","year":"2003","journal-title":"Comp. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0365","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S8756-3282(01)00679-2","article-title":"Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease","volume":"30","author":"Monroy","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0370","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.1998.tb02745.x","article-title":"Murine MPS I: insights into the pathogenesis of Hurler syndrome","volume":"53","author":"Russell","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0375","first-page":"207","article-title":"A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice","volume":"136","author":"Vogler","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2012.07.002","article-title":"Long circulating enzyme replacement therpay rescues bone pathology in mucopolysaccharidosis VII murine model","volume":"107","author":"Rowan","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0385","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ymthe.2003.07.004","article-title":"Improvement of skeletal lesions in mice with mucopolysaccharidosis type VII by neonatal adenoviral gene transfer","volume":"8","author":"Kanaji","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0390","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI117237","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII","volume":"93","author":"Sands","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0395","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0960-8966(97)00061-8","article-title":"Gene therapy for murine mucopolysaccharidosis type VII","volume":"7","author":"Sands","year":"1997","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0400","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1203\/00006450-199906000-00010","article-title":"Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy","volume":"45","author":"Vogler","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0405","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.gt.3301420","article-title":"Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer","volume":"8","author":"Daly","year":"2001","journal-title":"Gene. Ther."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0410","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2014-06-581207","article-title":"Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I","volume":"125","author":"Pievani","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0415","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jor.22281","article-title":"Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)","volume":"31","author":"Lai","year":"2013","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0425","first-page":"27","article-title":"The pathology of the feline model of mucopolysaccharidosis I","volume":"112","author":"Haskins","year":"1983","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0430","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/mgme.1999.2860","article-title":"Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats","volume":"67","author":"He","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0435","first-page":"487","article-title":"Morphologic and biochemical studies of canine mucopolysaccharidosis I","volume":"114","author":"Shull","year":"1984","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0440","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/030098589803500311","article-title":"Clinical and morphologic features of mucopolysaccharidosis type II in a dog: naturally occurring model of Hunter syndrome","volume":"35","author":"Wilkerson","year":"1998","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0445","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/geno.2000.6275","article-title":"Canine heparan sulfate sulfamidase and the molecular pathology underlying Sanfilippo syndrome type A in Dachshunds","volume":"68","author":"Aronovich","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1203\/00006450-199807000-00012","article-title":"Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A)","volume":"44","author":"Fischer","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0455","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/00480169.2000.36181","article-title":"Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia","volume":"48","author":"Jolly","year":"2000","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0460","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/geno.2002.6699","article-title":"Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs","volume":"79","author":"Yogalingam","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0465","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1023\/A:1025177411938","article-title":"A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-d-glucosaminidase deficiency in Schipperke dogs","volume":"26","author":"Ellinwood","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0470","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0925-4439(95)00054-8","article-title":"Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA","volume":"1271","author":"Friderici","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0475","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/BF01800018","article-title":"N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID)","volume":"15","author":"Thompson","year":"1992","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0480","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.144321","article-title":"Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome","volume":"198","author":"Jezyk","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0485","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1203\/00006450-197911000-00001","article-title":"Mucopolysaccharide storage disease in three families of cats with arylsulfatase B deficiency: leukocyte studies and carrier identification","volume":"13","author":"Haskins","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0490","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0925-4439(98)00112-4","article-title":"Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI","volume":"1453","author":"Yogalingam","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0495","first-page":"124","article-title":"Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) in a miniature pinscher","volume":"6","author":"Neer","year":"1992","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1939-1676.1995.tb03306.x","article-title":"Clinical vignette. Mucopolysaccharidosis VI in a miniature pinscher","volume":"9","author":"Neer","year":"1995","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0505","first-page":"980","article-title":"Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII","volume":"18","author":"Haskins","year":"1984","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0510","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/geno.1997.5189","article-title":"Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells","volume":"48","author":"Ray","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/geno.1999.5825","article-title":"Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII","volume":"58","author":"Fyfe","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0520","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/030098589403100405","article-title":"Feline mucopolysaccharidosis VII due to beta-glucuronidase deficiency","volume":"31","author":"Gitzelmann","year":"1994","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0525","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jor.21030","article-title":"Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII","volume":"28","author":"Smith","year":"2010","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0530","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bone.2013.03.014","article-title":"Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs","volume":"55","author":"Chiaro","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0535","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/8756-3282(95)00333-4","article-title":"Bone changes in mucopolysaccharidosis VI in cats and the effects of bone marrow transplantation: mechanical testing of long bones","volume":"17","author":"Norrdin","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0540","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00310257","article-title":"Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry","volume":"57","author":"Turner","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1242\/dmm.006403","article-title":"Degeneration and regeneration of the intervertebral disc: lessons from development","volume":"4","author":"Smith","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0550","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/ken396","article-title":"The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain","volume":"48","author":"Freemont","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0555","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(99)01312-4","article-title":"Epidemiological features of chronic low-back pain","volume":"354","author":"Andersson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0560","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0565","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0009-9260(96)80246-7","article-title":"Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II)","volume":"51","author":"Parsons","year":"1996","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0570","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/jbmr.2290","article-title":"Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs","volume":"29","author":"Chiaro","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0575","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2010.06.020","article-title":"Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I","volume":"101","author":"Dickson","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0580","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2012.03.013","article-title":"Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs","volume":"107","author":"Smith","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0585","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001380","article-title":"Replacing the enzyme alpha-l-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I","volume":"2","author":"Dierenfeld","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0590","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/PRM-2010-0120","article-title":"Cartilage and chondrocyte pathology in the mucopolysaccharidoses: the role of glycosaminoglycan-mediated inflammation","volume":"3","author":"Simonaro","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0595","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0600","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0605","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1471-4906(02)02317-7","article-title":"Endogenous ligands of toll-like receptors: implications for regulating inflammatory and immune responses","volume":"23","author":"Beg","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0610","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1172\/JCI23755","article-title":"The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages","volume":"115","author":"Schaefer","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0615","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2009.05.006","article-title":"Partial role of TLR4 as a receptor responding to damage-associated molecular pattern","volume":"125","author":"Lee","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0620","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1148\/89.1.67","article-title":"The various causes of scalloped vertebrae with notes on their pathogenesis","volume":"89","author":"Mitchell","year":"1967","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0625","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s13244-013-0246-8","article-title":"Imaging findings of mucopolysaccharidoses: a pictorial review","volume":"4","author":"Palmucci","year":"2013","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0630","article-title":"Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center","author":"Abelin Genevois","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0635","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","author":"Montano","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0640","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2008.07.003","article-title":"Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy","volume":"95","author":"Herati","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0645","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2015.09.008","article-title":"Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs","volume":"116","author":"Peck","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0650","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.cellbio.042308.113308","article-title":"Genetic control of bone formation","volume":"25","author":"Karsenty","year":"2009","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0655","first-page":"97","article-title":"A review of FGF18: its expression, signaling pathways and possible functions during embryogenesis and post-natal development","volume":"22","author":"Haque","year":"2007","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0660","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1534-5807(02)00261-7","article-title":"Interaction of FGF, Ihh\/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation","volume":"3","author":"Minina","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0665","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1242\/dev.128.22.4523","article-title":"BMP and Ihh\/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation","volume":"128","author":"Minina","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0670","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0675","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"FGF signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0680","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.bone.2007.01.005","article-title":"Wnt gene expression in the post-natal growth plate: regulation with chondrocyte differentiation","volume":"40","author":"Andrade","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0685","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1242\/jcs.00152","article-title":"Wnt regulation of chondrocyte differentiation","volume":"115","author":"Church","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0690","first-page":"30102","article-title":"Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease","volume":"16","author":"Kingma","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0695","article-title":"Low bone mineral content and challenges in interpretation of dual-energy X-ray absorptiometry in children with mucopolysaccharidosis types I, II, and VI","author":"Polgreen","year":"2013","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0700","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-8-71","article-title":"Assessment of bone mineral density by dual energy X-ray absorptiometry in patients with mucopolysaccharidoses","volume":"8","author":"Lin","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0705","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2015.11.013","article-title":"Bone mineral density in MPS IV A (Morquio syndrome type A)","volume":"117","author":"Kecskemethy","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0710","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/PRM-2010-0105","article-title":"Bone density assessment in patients with mucopolysaccharidosis: a preliminary report from patients with MPS II and VI","volume":"3","author":"Fung","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0715","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/PRM-140285","article-title":"Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI","volume":"7","author":"Stevenson","year":"2014","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0720","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2012.03.022","article-title":"Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII","volume":"106","author":"Macsai","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0725","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1111\/petr.12231","article-title":"Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler","volume":"18","author":"Ferrara","year":"2014","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0730","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s002470000210","article-title":"Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H)","volume":"30","author":"Hite","year":"2000","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0735","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10545-011-9309-5","article-title":"The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)","volume":"34","author":"Miebach","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0740","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","article-title":"Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy","volume":"34","author":"Manara","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0745","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000371658","article-title":"Cervical spine MRI findings in patients with mucopolysaccharidosis type II","volume":"50","author":"Zuber","year":"2015","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0750","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/BPO.0000000000000074","article-title":"Cervicothoracic myelopathy in children with Morquio syndrome A: a report of 4 cases","volume":"34","author":"Baratela","year":"2014","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0755","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1302\/0301-620X.55B3.478","article-title":"Atlanto-axial subluxation in the Morquio syndrome. Report of a case","volume":"55","author":"Beighton","year":"1973","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0760","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ajmg.a.36424","article-title":"Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement","volume":"164A","author":"Borlot","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0765","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2014.10.010","article-title":"Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome","volume":"114","author":"Charrow","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0770","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0775","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000334310","article-title":"Morquio's syndrome and craniocervical instability","volume":"47","author":"Houten","year":"2011","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0780","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archneurol.2010.308","article-title":"Atlantoaxial instability and cervical cord compression in Morquio syndrome","volume":"67","author":"Li","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0785","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2106\/00004623-197759030-00008","article-title":"Dysplasia of the odontoid process in Morquio's syndrome causing quadriparesis","volume":"59","author":"Lipson","year":"1977","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0790","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1399-0004.1988.tb03423.x","article-title":"Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part III: odontoid dysplasia","volume":"33","author":"Nelson","year":"1988","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0795","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10545-013-9585-3","article-title":"MRI morphometric characterisation of the paediatric cervical spine and spinal cord in children with MPS IVA (Morquio-Brailsford syndrome)","volume":"36","author":"Solanki","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0800","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1442-200X.1991.tb01877.x","article-title":"Diagnosis of atlantoaxial subluxation in Morquio's syndrome and spondyloepiphyseal dysplasia congenita","volume":"33","author":"Takeda","year":"1991","journal-title":"Acta Paediatr. Jpn."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0805","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3171\/2012.2.PEDS11522","article-title":"Spinal cord infarction remote from maximal compression in a patient with Morquio syndrome","volume":"9","author":"Tong","year":"2012","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0810","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ymgme.2011.07.019","article-title":"Spinal cord compression in young children with type VI mucopolysaccharidosis","volume":"104","author":"Horovitz","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0815","first-page":"849","article-title":"Craniovertebral abnormalities in Type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome)","volume":"48","author":"Thorne","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0820","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01241398-198901000-00015","article-title":"Atlantoaxial instability in mucopolysaccharidosis type VII","volume":"9","author":"Pizzutillo","year":"1989","journal-title":"J. Pediatr. Orthop."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2016.06.002_bb0825","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1007\/s10545-009-1265-y","article-title":"Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression","volume":"32","author":"Illsinger","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0830","first-page":"1402","article-title":"Cervical myelopathy secondary to Hunter syndrome in an adult","volume":"16","author":"Vinchon","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0835","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1227\/00006123-198709000-00027","article-title":"Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case","volume":"21","author":"Tamaki","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0840","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0090-3019(82)80004-9","article-title":"Cervical myelopathy due to dural compression in mucopolysaccharidosis","volume":"17","author":"Kaufman","year":"1982","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0845","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/PRM-2010-0102","article-title":"Orthopedic management of mucopolysaccharide disease","volume":"3","author":"White","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0850","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5435\/JAAOS-21-01-12","article-title":"Mucopolysaccharide disorders in orthopaedic surgery","volume":"21","author":"White","year":"2013","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0855","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0860","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","article-title":"Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review","volume":"34","author":"van der Linden","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0865","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1302\/0301-620X.98B2.36144","article-title":"Thoracolumbar kyphosis in patients with mucopolysaccharidoses: clinical outcomes and predictive radiographic factors for progression of deformity","volume":"98-B","author":"Roberts","year":"2016","journal-title":"Bone Joint J."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0870","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13059","article-title":"Transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"167","author":"Boelens","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0875","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.2016.1123690","article-title":"Emerging drugs for the treatment of mucopolysaccharidoses","volume":"21","author":"Giugliani","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0880","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009354.pub2","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme((R))) for treating mucopolysaccharidosis type I","volume":"11","author":"Jameson","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0885","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0890","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0895","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0900","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1651-2227.2008.00811.x","article-title":"Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT)","volume":"97","author":"Malm","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0905","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01241398-200401000-00019","article-title":"Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation","volume":"24","author":"Weisstein","year":"2004","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/BRS.0000000000000157","article-title":"Thoracolumbar kyphosis in treated mucopolysaccharidosis 1 (Hurler syndrome)","volume":"39","author":"Yasin","year":"2014","journal-title":"Spine"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0915","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2007.03.001","article-title":"Bone marrow transplantation for feline mucopolysaccharidosis I","volume":"91","author":"Ellinwood","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0920","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2014.10.017","article-title":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient","volume":"114","author":"Fox","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0925","doi-asserted-by":"crossref","first-page":"43160","DOI":"10.1074\/jbc.M107778200","article-title":"Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VII","volume":"276","author":"Sands","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0930","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0935","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/pr.2011.13","article-title":"Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats","volume":"71","author":"Auclair","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0940","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/138920111795542642","article-title":"Intrathecal enzyme replacement therapy for mucopolysaccharidosis I: translating success in animal models to patients","volume":"12","author":"Dickson","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0945","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2015.07.005","article-title":"Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I","volume":"116","author":"Dickson","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0950","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.dib.2015.08.004","article-title":"Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I","volume":"5","author":"Dickson","year":"2015","journal-title":"Data Brief"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0955","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ymgme.2009.11.008","article-title":"Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis","volume":"99","author":"Munoz-Rojas","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0960","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S8756-3282(97)00175-0","article-title":"Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI","volume":"21","author":"Byers","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0965","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2014.05.013","article-title":"Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0970","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/pr.2013.158","article-title":"Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients","volume":"74","author":"Vera","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0975","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1073\/pnas.192353499","article-title":"Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs","volume":"99","author":"Ponder","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0980","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.mt.6300201","article-title":"Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy","volume":"15","author":"Traas","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0985","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2016.06.002_bb0990","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2013.03.013","article-title":"The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade","volume":"109","author":"Xing","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb0995","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","article-title":"Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs","volume":"82","author":"Mango","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.06.002_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2016.06.002_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2016.06.002_bb1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153136","article-title":"Pentosan polysulfate: oral versus subcutaneous injection in mucopolysaccharidosis type I dogs","volume":"11","author":"Simonaro","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2016.06.002_bb1015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmat2116","article-title":"Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage","volume":"7","author":"Rothenfluh","year":"2008","journal-title":"Nat. Mater."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T10:55:45Z","timestamp":1718621745000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216300956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":203,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1096719216300956"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.06.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and treatment of spine disease in the mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.ymgme.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}